Cardiac Pacing and Defibrillation

  • Henry H. Hsia


After reading this chapter you should be able to do the following: Be familiar with the coding of implantable pacemakers and implantable cardioverter-defibrillators (ICDs). Understand the basic operations of implantable devices. Be familiar with the indications of implantable pacemakers and ICDs. Be familiar with the indications for cardiac resynchronization therapy (CRT). Be able to systematically evaluate possible device malfunctions. Be able to better manage patients with implantable devices.


Cardiac Resynchronization Therapy Antiarrhythmic Drug Implantable Device Complete Heart Block Supraventricular Arrhythmia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Andersen H, Nielsen J, Thomsen PE, et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997;350:1210–1216.PubMedCrossRefGoogle Scholar
  2. 2.
    Connolly S, Kerr C, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med. 2000;342:1385–1391.PubMedCrossRefGoogle Scholar
  3. 3.
    Nielsen J, Kristensen L, Andersen H, Mortensen P, Pedersen O, Pedersen A. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome. J Am Coll Cardiol. 2003;42:614–623.PubMedCrossRefGoogle Scholar
  4. 4.
    Sweeney M, Hellkamp A, Ellenbogen K, et al. Mode selection trial. Circulation. 2003;107:2932–2937.PubMedCrossRefGoogle Scholar
  5. 5.
    Ideker R, Zhou X, Knisley S. Correlation among fibrillation, defibrillation and cardiac pacing. PACE. 1995;18:512–525.PubMedCrossRefGoogle Scholar
  6. 6.
    Dillon S, Kwaku K. Progressive depolarization: A unified hypothesis for defibrillation and fibrillation induction by shocks. J Cardiovasc Electrophysiol. 1998;9:529–552.PubMedCrossRefGoogle Scholar
  7. 7.
    Antiarrhythmic versus Implantable Defibrillators (AVID) Investi­gators. A comparison of antiarrhythmic-drug therapy with implant­able defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576–1583.Google Scholar
  8. 8.
    Kuck K, Cappato R, Siebels J, Rüppel R. The Cardiac Arrest Study Hamburg (CASH) Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. Circulation. 2000;102:748–754.PubMedCrossRefGoogle Scholar
  9. 9.
    Connolly S, Gent M, Roberts R, et al. A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297–1302.PubMedCrossRefGoogle Scholar
  10. 10.
    Moss A, Hall J, Cannon D, et al. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933–1940.PubMedCrossRefGoogle Scholar
  11. 11.
    Buxton A, Lee K, Fisher J, Josephson M, Prystowsky E, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–1890.PubMedCrossRefGoogle Scholar
  12. 12.
    Moss A, Wojciech Z, Hall W, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883.PubMedCrossRefGoogle Scholar
  13. 13.
    Bardy G, Lee K, Mark D, et al. Amiodarone or an implantable cardioverter – defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237.PubMedCrossRefGoogle Scholar
  14. 14.
    Kadish A, Dyer A, Daubert J, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–2158.PubMedCrossRefGoogle Scholar
  15. 15.
    Olson W. Tacharrhythmia sensing and detection. In:Singer I, ed. implantable cardiovrater-defibrillator. Armonk, NY: Futura;1947:71–107.Google Scholar
  16. 16.
    Miller J, Hsia H. Management of the patient with frequent discharges from implantable cardioverter defibrillator devices. J Cardiovasc Electrophysiol. 1996;7:278–285.PubMedCrossRefGoogle Scholar
  17. 17.
    Nahlawi M, Waligora M, Spies S, Bonow R, Kadish A, Goldberger J. Left ventricular function during and after right ventricular pacing. J Am Coll Cardiol. 2004;44:1883–1888.PubMedCrossRefGoogle Scholar
  18. 18.
    Zhang X, Chen H, Siu C, et al. New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function. J Cardiovasc Electrophysiol. 2008;19:136–141.PubMedCrossRefGoogle Scholar
  19. 19.
    Geiger M, O’Neill P, Sharma A, et al. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. PACE. 1997;20:624–630.PubMedCrossRefGoogle Scholar
  20. 20.
    Leclercq C, Bleeker G, Linde C, et al. Cardiac resynchronization therapy: Clinical results and evolution of candidate selection. Eur Heart J. 2007;9:I94–I106.CrossRefGoogle Scholar
  21. 21.
    Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–880.PubMedCrossRefGoogle Scholar
  22. 22.
    Abraham W, Fisher W, Smith A, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853.PubMedCrossRefGoogle Scholar
  23. 23.
    Abraham W, Hayes D. Cardiac resynchronization therapy for heart failure. Circulation. 2003;108:2596–2603.PubMedCrossRefGoogle Scholar
  24. 24.
    Auricchio A, Stellbrink C, Sack S, et al. Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:2026–2033.PubMedCrossRefGoogle Scholar
  25. 25.
    Young JB, Abraham WT, Smith AL, et al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685–2694.PubMedCrossRefGoogle Scholar
  26. 26.
    Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42:1454–1459.PubMedCrossRefGoogle Scholar
  27. 27.
    Skanes AC, Krahn AD, Yee R, et al. Canadian Trial of Physiologic Pacing (CTOPP) Investigators. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. J Am Coll Cardiol. 2001, 38: 167–172.PubMedCrossRefGoogle Scholar
  28. 28.
    Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288:31150–3123.Google Scholar
  29. 29.
    Singer I, Lang D. The defibrillation threshold. In: Kroll M, Lehmann M, eds. Implantable Cardioverter-Defibrillator Therapy: The Engineer-Clinical Interface. Norwell, MA. Kluwer Academic Publishers; 1996:89–130.CrossRefGoogle Scholar

Additional Reading

  1. Ellenbogen KA, Wood MA, eds. Cardiac Pacing and ICDs. 4th ed. USA: Blackwell; 2005.Google Scholar
  2. Kroll MW, Lehmann MH, eds. Implantable Cardioverter Defibrillator Therapy: The Engineering-Clinical Interface. USA: Kluwer Academic; 1996.Google Scholar
  3. Allessie MA, Fromer M, eds. Atrial and Ventricular Fibrillation: Mechanisms and Device Therapy. Armonk, NY: Futura; 1997.Google Scholar
  4. ACC/AHA/HRS guidelines for device-based therapy: executive summary. JACC. 2008;51(21):2085-2105.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Henry H. Hsia
    • 1
  1. 1.Department of Cardiovascular MedicineStanford University Medical CenterStanfordUSA

Personalised recommendations